Record growth in surgical robotics market
Ten post jest także dostępny w języku: polski
Global surgical robotics leader Intuitive Surgical has reported that the company delivered 298 da Vinci surgical systems in the first quarter of 2021, an increase, up 26% compared to the same period in 2020. The number of robots installed worldwide thus increased to 6,142. The global number of procedures using the da Vinci robot also increased – by around 16%.
The da Vinci robot is used mainly in the treatment of oncological conditions, including simple cancer, endometrial cancer and colorectal cancer. The growing problem of increasing cancer incidence and the need to improve oncological treatment results by increasing access to technology also contribute to the popularisation of the da Vinci system in Poland.
The dynamic growth of sales of da Vinci robots is supported by effective tools under operating leasing and on the basis of contracts of use, in this model nearly 43% of all da Vinci robots from the first quarter of 2021 were deployed on the market. The Polish market may also accelerate growth thanks to the increased use of such tools. The development of the market can also benefit banks and financing institutions, which have a properly prepared offer – says Joanna Szyman, vice president of Upper Finanse.
Da Vinci robots in Poland
Poland already has 14 authorised da Vinci surgical robots and, according to a report entitled “Market of surgical robotics in Poland 2020” published by Upper Finance and PMR, their number is likely to grow rapidly in the coming years to reach 40-50 installations in 2025.
Over 100,000 people die each year due to cancer in Poland. According to a report by the European Commission, up to 40% of these deaths could be avoided if the diagnosis were made earlier or if patients had better access to the latest treatment methods. This is why European Funds also support the development of robotic surgery in Poland. An example is the research and development initiative carried out in Kraków at the Hospital at Kliny, about which we wrote more here.